Blueshift Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$16.89 - $35.01 $278,380 - $577,034
16,482 New
16,482 $434,000
Q2 2022

Aug 12, 2022
SELL
$5.21 - $12.14 $113,734 - $265,016
-21,830 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$7.34 - $17.16 $160,232 - $374,602
21,830 New
21,830 $222,000

Others Institutions Holding BBIO

# of Institutions
291
Shares Held
171M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.92B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email